Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 102 results found. Search for [ biological products ]

Results 1 to 21 of 102
E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
June 25, 2020
The report by the German state of Baden-Wurttemberg states that Germany is an important area of operation for Iran, Pakistan, North Korea and Syria for securing relevant know-how through illegal procurement from the country


Chitranjan Kumar
New Delhi, June 19, 2020
On progress on treatment options for COVID-19, Cadila said it is working on a DNA vaccine to fight coronavirus, which is currently in the animal testing stage


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


E Kumar Sharma
June 4, 2020
Swaminathan, who is arguably a go-to guru on issues related to farmers, believes that we can double farmer's income through appropriate marketing and by ensuring that they get a fair price


BusinessToday.In
New Delhi, June 1, 2020
Coronavirus vaccine news: In China, more than 2,000 people have been administered coronavirus vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products


BusinessToday.In
New Delhi, May 31, 2020
Coronavirus vaccine update: Over 100 experimental COVID-19 vaccines are in various stages of development; from US-based Moderna Inc to China's CanSino Pharmaceuticals -- some of the world's biggest companies are in race to develop coronavirus vaccine


BusinessToday.In
May 17, 2020
Coronavirus vaccine update: World leaders and organisations except the United States have already pledged $8 billion to research, manufacture, and distribute a possible vaccine and treatment for COVID-19


PB Jayakumar
New Delhi, May 12, 2020
Pharmaceutical players will set up plants in major markets, go for more automation and focus on digital marketing


BusinessToday.In
New Delhi, May 11, 2020
Coronavirus crisis: Researchers across the globe are working on the vaccine for COVID-19, with some vaccine candidates at an advanced stage of clinical trial


BusinessToday.In
May 9, 2020
Globally, efforts are underway to develop a vaccine to treat Covid 19 which has stalled economic activity and led to death of over 2.77 lakh people across the world


BusinessToday.In
New Delhi, May 6, 2020
United States has been worst affected nation with 72,275 deaths, followed by the UK, Italy and Spain; as spread of coronavirus shows no sign of slowing down, researchers and various governments are doubling efforts to develop a vaccine


PB Jayakumar
May 6, 2020
Regulatory agencies have fast-tracked the vaccine development, which normally takes 7-10 years to reach the market


BusinessToday.In
New Delhi, May 5, 2020
Covid-19 Vaccine: Check latest news and updates on coronavirus vaccine, when will coronavirus vaccine be ready, all you need to know about coronavirus vaccine production


PB Jayakumar
New Delhi, April 13, 2020
Sources said the ICMR's initial orders for 5 lakh kits included the Chinese firm Wondfo, which has the NMPA clearance. Nevertheless the firm did not honour its commitment


Goutam Das
New Delhi, March 17, 2020
Amazon in India believes in scaling up faster using technology, simplifying processes and rigorously auditing itself to disrupt and reinvent HR industry standards


Dr S. Raghunath
March 13, 2020
The emergence of the COVID-19 threat and confluence of a company's capability and behaviour can lead to moats that are exceptionally rare given the challenging circumstances


BusinessToday.In
New Delhi, March 5, 2020
Chandrayaan-III will cost approximately Rs 615 crore, which far less than Chandrayaan-2 mission cost of around Rs 970 crore


PAGES 1 OF 6  12345